Cytokinetics
CYTK
$65.34
Share price
0.83%
Change (1 day)
74.71%
Change (1 year)
Categories
Operating Margin for Cytokinetics (CYTK)
Operating Margin as of April 2024 (TTM): -5,422.18%
According to Cytokinetics 's latest financial reports and stock price the company's current Operating Margin is -5,422.18%. At the end of 2022 the company had an Operating Margin of -411.21%.
Operating Margin history for Cytokinetics from 2003 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -411.21% | 34.5% |
| 2021 | -305.72% | 34.09% |
| 2020 | -228.00% | -49.66% |
| 2019 | -452.93% | 34.23% |
| 2018 | -337.41% | -64.7% |
| 2017 | -955.94% | -6282.38% |
| 2016 | 15.46% | -111.82% |
| 2015 | -130.86% | 319.39% |
| 2014 | -31.20% | -71.64% |
| 2013 | -110.01% | -78.69% |
| 2012 | -516.14% | -56.86% |
| 2011 | -1,196.50% | -37.66% |
| 2010 | -1,919.40% | -6437.74% |
| 2009 | 30.29% | -106.64% |
| 2008 | -455.76% | 9.91% |
| 2007 | -414.67% | -78.86% |
| 2006 | -1,961.56% | 291.67% |
| 2005 | -500.82% | 75.16% |
| 2004 | -285.92% | -7.2% |
| 2003 | -308.12% | 46.42% |
| 2002 | -210.43% | -3.14% |
| 2001 | -217.25% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 34.59% | -100.64% | 🇺🇸 USA |
 Trevena TRVN | -24,856.30% | 358.42% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 17.06% | -100.31% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -84.50% | -98.44% | 🇺🇸 USA |
 Array Technologies ARRY | 12.31% | -100.23% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.